Crossmark

CHECKvacc (HOV3, CF33-hNIS-anti-PD-L1), the next medical revolution against cancer

Crossref DOI link: https://doi.org/10.1016/j.vacun.2023.01.006

Published Print: 2023-10

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Dawood, Ali Adel
Funding

Funding for this research was provided by:

University of Mosul
License Information

Text and Data Mining valid from 2023-10-01
More Information

This article is maintained by: Elsevier

Article Title: CHECKvacc (HOV3, CF33-hNIS-anti-PD-L1), the next medical revolution against cancer

Journal Title: Vacunas

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.vacun.2023.01.006

Content Type: article

Copyright: Published by Elsevier España, S.L.U.